1. Home
  2. CNOBP vs BRTX Comparison

CNOBP vs BRTX Comparison

Compare CNOBP & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ConnectOne Bancorp Inc.

CNOBP

ConnectOne Bancorp Inc.

HOLD

Current Price

$25.28

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

N/A

Current Price

$2.64

Market Cap

5.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CNOBP
BRTX
Founded
N/A
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Managed Health Care
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
5.4M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
CNOBP
BRTX
Price
$25.28
$2.64
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.7K
250.9K
Earning Date
N/A
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.51
N/A
Revenue
N/A
$81,000.00
Revenue This Year
N/A
$298.39
Revenue Next Year
N/A
$64.62
P/E Ratio
$16.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.78
$0.14
52 Week High
$25.51
$4.10

Technical Indicators

Market Signals
Indicator
CNOBP
BRTX
Relative Strength Index (RSI) 60.16 63.20
Support Level $24.87 $0.45
Resistance Level $25.48 $4.10
Average True Range (ATR) 0.08 0.38
MACD 0.01 0.22
Stochastic Oscillator 60.63 64.48

Price Performance

Historical Comparison
CNOBP
BRTX

About CNOBP ConnectOne Bancorp Inc.

ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets, and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental, and consumer wages.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.

Share on Social Networks: